Results 161 to 170 of about 24,520 (233)

Recent Advances in Photocatalyst‐Driven Protein Labeling and Proximity Mapping

The Chemical Record, Volume 26, Issue 8, August 2026.
Photocatalyst‐driven protein labeling and proximity mapping have rapidly advanced as powerful strategies for spatiotemporal control in complex biological environments. This review integrates recent developments across single‐electron transfer and energy transfer‐based mechanisms and highlights how catalyst design, reactive intermediates, and diffusion ...
Shinichi Sato, Kazuki Miura, Juki Nakao, Hiroyuki Nakamura   +3 more
wiley   +1 more source

CD47 as a prognostic biomarker and potential immunotherapy target in penile squamous cell carcinoma. [PDF]

Sci Rep
Zhang J, Hu X, Xu J, Ai C, Wang H, Xie X, Ao Y, Tan J, Jin J, Liu G, Huang Y, Lan W.   +11 more
europepmc   +1 more source

The changing epidemiology of human type 2 diabetes–associated atherosclerosis: Pathophysiological mechanisms and emerging treatment possibilities

Journal of Internal Medicine, Volume 300, Issue 2, Page 131-152, August 2026.
Abstract Type 2 diabetes (T2D) is a major global health concern strongly associated with atherosclerosis and subsequent macrovascular complications. These complications are the leading cause of death among T2D patients. Despite a decline in cardiovascular events over the last decade, individuals with T2D still have an approximately doubled risk ...
Dania Al‐Sharify, Jiangming Sun, Andreas Edsfeldt   +2 more
wiley   +1 more source

Targeting the CD47/SIRPα interaction in cancer: opportunities in non-Hodgkin lymphoma. [PDF]

Expert Opin Investig Drugs
Pagès-Geli C, Weiskopf K.
europepmc   +1 more source

Emerging Immune‐Based Therapeutic Strategies in Hepatocellular Carcinoma

Liver International, Volume 46, Issue 8, August 2026.
ABSTRACT Hepatocellular carcinoma (HCC) remains a leading cause of cancer‐related mortality worldwide despite recent advances in systemic therapy. The introduction of immune checkpoint inhibitors has substantially expanded treatment options for advanced disease; however, durable responses are observed only in a subset of patients.
Janine Kah, Werner Dammermann, Stefan Lueth   +2 more
wiley   +1 more source

Establishment of Predictive Models for Second Hepatoma Recurrence. [PDF]

Cancer Manag Res
Su M, Zhong W, Chen Z, Zhang G.
europepmc   +1 more source

Impact of Anatomical Localization on Systemic Inflammatory Markers and Immune Checkpoint CD47 in Desmoid Tumors. [PDF]

J Clin Med
Yaslikaya S, Atas Ipek S, Balikci Cicek I, Asarkaya E, Asoglu H, Ergozoglu MA, Turker M, Aydinalp Camadan Y, Kidi MM, Biter S, Koseci T, Eren Ates K, Bayram E, Gonlusen G, Kara IO.   +14 more
europepmc   +1 more source

CD47 Antagonist ALX148 [PDF]

, 2020
openaire   +1 more source

Nature-Inspired Alternatives to PEG for Next-Generation Long-Circulating Nanocarriers. [PDF]

Int J Nanomedicine
Jan N, Rejili M.
europepmc   +1 more source

Photodynamic therapy with zinc phthalocyanine suppresses immune checkpoints in human melanoma cells. [PDF]

Lasers Med Sci
Doustvandi MA, Hajizadeh M, Mohammadnejad F, Karamali N, Yari AH, Nobari SA, Baradaran B.   +6 more
europepmc   +1 more source